Consequently, metformin therapy reducing hyperglycemia and insulin resistance, may revert the systemic inflammation/oxidative stress in obese patients with prediabetic condition with SIRT1 modulation (Seifarth et al., 2013; Song et al., 2015; Xu et al., 2015). Here, SIRT1 is linked to Hyperglycemia.